Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Anemia

Free Subscription Articles published in Leukemia Retrieve available abstracts of 26 articles: HTML format

Single Articles

March 2008
1. DE VRIES AC , Langerak AW, Verhaaf B, Niemeyer CM, et al
   T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
   Leukemia. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. HUANG TC , Ko BS, Tang JL, Hsu C, et al
   Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.
   Leukemia. 2008;22:544-50.
   PubMed     Related articles    Abstract available
   
   
   
3. GARCIA-MANERO G , Shan J, Faderl S, Cortes J, et al
   A prognostic score for patients with lower risk myelodysplastic syndrome.
   Leukemia. 2008;22:538-43.
   PubMed     Related articles    Abstract available
   
   
   December 2007
4. MENIER C , Guillard C, Cassinat B, Carosella ED, et al
   HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.
   Leukemia. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
5. ATALLAH E , Nussenzveig R, Yin CC, Bueso-Ramos C, et al
   Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
   Leukemia. 2007;.
   PubMed     Related articles   
   
   
   
6. RAVINDRANATHAN M , Klementich FJ, Jones DV Jr
   Potential interaction of chemotherapy and gefitinib in the induction of hematologic neoplasia.
   Leukemia. 2007;21:2546-7.
   PubMed     Related articles   
   
   
   September 2007
7. MESA RA , Camoriano JK, Geyer SM, Wu W, et al
   A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia.
   Leukemia. 2007;21:1964-70.
   PubMed     Related articles    Abstract available
   
   
   August 2007
8. PRADE-HOUDELLIER N , Frebet E, Demur C, Gautier EF, et al
   Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells.
   Leukemia. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
9. KRATZ CP , Niemeyer CM, Karow A, Volz-Fleckenstein M, et al
   Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation.
   Leukemia. 2007;.
   PubMed     Related articles   
   
   
   
10. SCHNITTGER S , Bacher U, Haferlach C, Dengler R, et al
    Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
11. LE BLANC K , Samuelsson H, Gustafsson B, Remberger M, et al
    Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
    Leukemia. 2007;21:1733-8.
    PubMed     Related articles    Abstract available
    
    
    
12. PORTA G , Maserati E, Mattarucchi E, Minelli A, et al
    Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCR.
    Leukemia. 2007;21:1833-5.
    PubMed     Related articles   
    
    
    April 2007
13. ROYER B , Vaida I, Etienne A, Garidi R, et al
    Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
14. LAURENTI L , Tarnani M, Efremov DG, Chiusolo P, et al
    Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
15. LUNDIN J
    Reply to 'Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia' by Dr Laurenti et al.
    Leukemia. 2007;.
    PubMed     Related articles   
    
    
    
16. HEDENUS M , Birgegard G, Nasman P, Ahlberg L, et al
    Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study.
    Leukemia. 2007;21:627-32.
    PubMed     Related articles    Abstract available
    
    
    February 2007
17. MATSUDA A , Germing U, Jinnai I, Iwanaga M, et al
    Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
18. KARLSSON C , Hansson L, Celsing F, Lundin J, et al
    Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Leukemia. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
19. BORRIELLO A , Locasciulli A, Bianco AM, Criscuolo M, et al
    A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.
    Leukemia. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
20. CEESAY MM , Lea NC, Ingram W, Westwood NB, et al
    The JAK2 V617F mutation is rare in RARS but common in RARS-T.
    Leukemia. 2006;20:2060-1.
    PubMed     Related articles   
    
    
    September 2006
21. RENNEVILLE A , Quesnel B, Charpentier A, Terriou L, et al
    High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Leukemia. 2006;.
    PubMed     Related articles   
    
    
    
22. ORAZI A
    Quantification of marrow CD34+ cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia.
    Leukemia. 2006;.
    PubMed     Related articles   
    
    
    
23. MATSUI WH , Brodsky RA, Smith BD, Borowitz MJ, et al
    Reply to 'Quantification of marrow CD34+ cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia' by A Orazi.
    Leukemia. 2006;.
    PubMed     Related articles   
    
    
    July 2006
24. WANG SA , Hasserjian RP, Loew JM, Sechman EV, et al
    Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features.
    Leukemia. 2006;.
    PubMed     Related articles   
    
    
    June 2006
25. MUNDLE SD , Raza A
    Treatment of myelodysplastic syndromes with exogenous erythropoietin: a new therapeutic paradigm.
    Leukemia. 2006;.
    PubMed     Related articles   
    
    
    
26. POULAIN S , Dervite I, Leleu X, Fernandes J, et al
    Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenstrom's macroglobulinemia: association with FcgammaRIIa polymorphism.
    Leukemia. 2006;20:1179-81.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

This E-mail is provided by AMEDEO through an unrestricted educational grant from www.AnaemiaWorld.com, a Roche service.

Amedeo is a Bernd Sebastian Kamps website.    Design: